In vitro screening for population variability in chemical toxicity.

Immortalized human lymphoblastoid cell lines have been used to demonstrate that it is possible to use an in vitro model system to identify genetic factors that affect responses to xenobiotics. To extend the application of such studies to investigative toxicology by assessing interindividual and population-wide variability and heritability of chemical-induced toxicity phenotypes, we have used cell lines from the Centre d'Etude du Polymorphisme Humain (CEPH) trios assembled by the HapMap Consortium. Our goal is to aid in the development of predictive in vitro genetics-anchored models of chemical-induced toxicity. Cell lines from the CEPH trios were exposed to three concentrations of 14 environmental chemicals. We assessed ATP production and caspase-3/7 activity 24 h after treatment. Replicate analyses were used to evaluate experimental variability and classify responses. We show that variability of response across the cell lines exists for some, but not all, chemicals, with perfluorooctanoic acid (PFOA) and phenobarbital eliciting the greatest degree of interindividual variability. Although the data for the chemicals used here do not show evidence for broad-sense heritability of toxicity response phenotypes, substantial cell line variation was found, and candidate genetic factors contributing to the variability in response to PFOA were investigated using genome-wide association analysis. The approach of screening chemicals for toxicity in a genetically defined yet diverse in vitro human cell-based system is potentially useful for identification of chemicals that may pose a highest risk, the extent of within-species variability in the population, and genetic loci of interest that potentially contribute to chemical susceptibility.

[1]  Andrew Worth,et al.  Metabolism: A Bottleneck in In Vitro Toxicological Test Development , 2006, Alternatives to laboratory animals : ATLA.

[2]  Jing Shi,et al.  Coupling cytotoxicity biomarkers with DNA damage assessment in TK6 human lymphoblast cells. , 2010, Mutation research.

[3]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[4]  Elliott Kieff,et al.  Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines , 2008, PLoS genetics.

[5]  Thomas Hartung,et al.  Are in vitro tests suitable for regulatory use? , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[7]  Ivan Rusyn,et al.  Toxicogenetics: population-based testing of drug and chemical safety in mouse models. , 2010, Pharmacogenomics.

[8]  V. Cheung,et al.  Transcriptional response of lymphoblastoid cells to ionizing radiation. , 2003, Genome research.

[9]  J. Cohen,et al.  Generation of Epstein‐Barr Virus (EBV)–Immortalized B Cell Lines , 1991, Current protocols in immunology.

[10]  J. Tracy,et al.  Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[12]  C. Miller,et al.  CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. , 1993, Carcinogenesis.

[13]  K. Broman,et al.  An Extension of the Regression of Offspring on Mid‐Parent to Test for Association and Estimate Locus‐Specific Heritability: The Revised ROMP Method , 2007, Annals of human genetics.

[14]  Ruili Huang,et al.  Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening. , 2008, Chemical research in toxicology.

[15]  R. Guigó,et al.  Transcriptome genetics using second generation sequencing in a Caucasian population , 2010, Nature.

[16]  Aldi Kraja,et al.  Genome-wide discovery of loci influencing chemotherapy cytotoxicity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Steven K. Gibb Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[18]  N. Kudo,et al.  Sex hormone-regulated renal transport of perfluorooctanoic acid. , 2002, Chemico-biological interactions.

[19]  C. Sempoux,et al.  Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes. , 1999, Pharmacogenetics.

[20]  Ivan Rusyn,et al.  Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. , 2008, Expert opinion on drug metabolism & toxicology.

[21]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[22]  C. Elcombe,et al.  Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Jonathan I Levy,et al.  Science and Decisions: Advancing Risk Assessment , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[24]  Alison C Cullen,et al.  The Application of Genetic Information for Regulatory Standard Setting Under the Clean Air Act: A Decision‐Analytic Approach , 2008, Risk analysis : an official publication of the Society for Risk Analysis.

[25]  Nilanjan Chatterjee,et al.  Estimation of effect size distribution from genome-wide association studies and implications for future discoveries , 2010, Nature Genetics.

[26]  Ruili Huang,et al.  Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening , 2007, Environmental health perspectives.

[27]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[28]  J. Watters,et al.  CEPH individuals are representative of the European American population: implications for pharmacogenetics. , 2005, Pharmacogenomics.

[29]  Melvin E Andersen,et al.  Toxicity testing in the 21st century: bringing the vision to life. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  M. Rosen,et al.  Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. , 2007, Toxicology.

[31]  G. Siest,et al.  Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects , 2008, Drug Metabolism and Disposition.

[32]  M. Eileen Dolan,et al.  A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity , 2007, Proceedings of the National Academy of Sciences.

[33]  R. Judson,et al.  The Toxicity Data Landscape for Environmental Chemicals , 2008, Environmental health perspectives.

[34]  E. Cook,et al.  Heritability and Linkage Analysis of Sensitivity to Cisplatin-Induced Cytotoxicity , 2004, Cancer Research.

[35]  Paul D Jones,et al.  Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  P. Lam,et al.  Differential expression of chicken hepatic genes responsive to PFOA and PFOS. , 2007, Toxicology.